Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. daily Stock Chart
Amgen Inc.
IndexS&P 500 P/E15.43 EPS (ttm)12.13 Insider Own0.10% Shs Outstand655.33M Perf Week-4.63%
Market Cap122.61B Forward P/E12.88 EPS next Y14.52 Insider Trans-3.43% Shs Float635.90M Perf Month-2.78%
Income8.30B PEG3.32 EPS next Q3.28 Inst Own79.90% Short Float1.58% Perf Quarter-7.53%
Sales23.32B P/S5.26 EPS this Y7.30% Inst Trans-1.51% Short Ratio3.39 Perf Half Y0.49%
Book/sh22.25 P/B8.41 EPS next Y1.95% ROA3.10% Target Price204.80 Perf Year5.68%
Cash/sh45.66 P/C4.10 EPS next 5Y4.65% ROE12.60% 52W Range163.31 - 210.19 Perf YTD7.59%
Dividend5.80 P/FCF17.65 EPS past 5Y14.40% ROI14.00% 52W High-10.99% Beta1.41
Dividend %3.10% Quick Ratio2.80 Sales past 5Y5.80% Gross Margin82.60% 52W Low14.57% ATR5.35
Employees20800 Current Ratio3.10 Sales Q/Q2.30% Oper. Margin43.40% RSI (14)37.74 Volatility2.47% 2.77%
OptionableYes Debt/Eq2.40 EPS Q/Q3.90% Profit Margin9.40% Rel Volume1.06 Prev Close190.08
ShortableYes LT Debt/Eq2.05 EarningsJan 29 AMC Payout135.60% Avg Volume2.97M Price187.10
Recom2.30 SMA20-4.83% SMA50-4.41% SMA200-1.06% Volume3,140,749 Change-1.57%
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Dec-18-18 05:50PM  Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know Zacks
05:18PM  Why a kidney disease drug approval in China is just the start for this S.F. company American City Business Journals
04:00PM  Amgen Engages Cambridge Biotech Community To Select 2018 LabCentral Golden Ticket Winners PR Newswire
11:00AM  S&P 500 Q3 2018 Buybacks Surpass $200 Billion Mark for the First Time Ever PR Newswire
10:15AM  Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma Zacks
09:50AM  Teva Reports Positive Top-Line Data for Migraine Candidate Zacks
09:19AM  Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018 Motley Fool
Dec-17-18 04:56PM  Pfizer's (PFE) Biosimilar of Avastin Gets Positive CHMP Nod Zacks
12:25PM  7 Major Pharmaceutical Stocks to Quarantine Now InvestorPlace
09:00AM  Amgen Submits Biologics License Application for ABP 710 (Biosimilar Infliximab) To US Food And Drug Administration PR Newswire
Dec-15-18 06:30AM  Better Buy: Biogen vs. Amgen Motley Fool
Dec-14-18 04:00PM  FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia PR Newswire
02:11PM  12 Stocks You Should Never Sell Kiplinger
08:23AM  5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019 Zacks
07:59AM  5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride Zacks
Dec-13-18 04:00PM  Amgen And Direct Relief Partner To Aid Cancer Patients In 18 Developing Countries PR Newswire
07:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Dec-12-18 05:50PM  Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
04:51PM  Why Arrowhead Pharmaceuticals Surged 11% Higher Today Motley Fool
12:13AM  Arrowhead Pharmaceuticals (ARWR) Q4 2018 Earnings Conference Call Transcript Motley Fool
Dec-11-18 04:00PM  Amgen And Magellan Rx Management Collaborate To Improve Patient Care For Chronic, Difficult-To-Treat Conditions PR Newswire
09:32AM  Entera shares jump 11.5% on news of collaboration with Amgen MarketWatch
Dec-10-18 04:41PM  Amgen And Lazarex Cancer Foundation Team Up To Allow More Diversity In Clinical Trials PR Newswire
09:13AM  Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend Zacks
Dec-09-18 11:56AM  Amgen Increases Quarterly Dividend
Dec-08-18 09:38PM  Is AbbVie Inc (ABBV) A Good Stock To Buy? Insider Monkey
10:07AM  Is Amgen, Inc. (AMGN) A Good Stock To Buy? Insider Monkey
Dec-07-18 04:06PM  Amgen raises dividend by 10% MarketWatch
04:00PM  Amgen Announces 10 Percent Increase In 2019 First Quarter Dividend PR Newswire
02:34PM  Amgen Falls 3%
Dec-06-18 08:39PM  [$$] Congress to Drug Makers: Why Stock Buybacks Over Lowered Drug Prices? The Wall Street Journal
Dec-05-18 10:19AM  10 Stocks to Buy When the Yield Curve Inverts InvestorPlace
09:10AM  Biotech Stock Roundup: ASH Meet in Focus, Gilead's Drugs Get Approval in China Zacks
08:45AM  Roche's Tecentriq Combination Gets Priority Review by FDA Zacks
08:17AM  Can Celgene and bluebird bio Survive a Two-Pronged Attack? Motley Fool
Dec-04-18 04:34PM  Amgen's BiTE Immunotherapies Show Promise in Early Studies Zacks
07:59AM  The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO Benzinga
12:23AM  Amgen antibody shows promise in myeloma trial, gets FDA fast track Reuters
Dec-03-18 09:15PM  Amgen Announces First-In-Human Data Evaluating Investigational Novel BiTE® Immunotherapies AMG 420 And AMG 330 At ASH 2018 PR Newswire
04:00PM  Amgen To Present At The Citi Global Healthcare Conference PR Newswire
03:36PM  Amgen Falls 3%
10:18AM  Could Amgen Incs (NASDAQ:AMGN) Investor Composition Influence The Stock Price? Simply Wall St.
09:55AM  AbbVie Settles With Pfizer for Humira Biosimilar in U.S. Zacks
09:41AM  FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate Zacks
Dec-02-18 05:51PM  The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs Benzinga
Nov-30-18 04:16PM  Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar Investor's Business Daily
04:00PM  Amgen And UCB Announce FDA Advisory Committee Meeting To Review EVENITY (romosozumab) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture PR Newswire
07:30AM  Good News Is on the Way for Blood Cancer Patients
Nov-29-18 05:50PM  Amgen (AMGN) Gains As Market Dips: What You Should Know Zacks
08:40AM  Research Report Identifies Equinix, Universal Electronics, LHC Group, Cohbar, Amgen, and Aetna with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-28-18 05:48PM  Novartis (NVS) Receives EC Approval for Neulasta Biosimilar Zacks
04:00PM  Amgen To Webcast Investor Call At ASH 2018 PR Newswire
02:30PM  Novartis' Biosimilar to Amgen's Neulasta Approved in Europe
12:47PM  3 Themes To Watch As Biopharmas 'Bring Some Excitement' In Blood Cancer Investor's Business Daily
07:38AM  3 Big Stock Charts for Wednesday: Delta Air Lines, Amgen and Mondelez International InvestorPlace
Nov-27-18 05:33PM  Health Care Stocks May Be Safe Haven in Event of Market Downturn
04:35PM  Why Celgene's Blockbuster Cancer Drug Looks Safe For Now Investor's Business Daily
11:22AM  5 Biotech Stocks to Scoop Up for Big Dividends InvestorPlace
Nov-26-18 05:28PM  Google asks for refund of campaign contribution to embattled Sen. Cindy Hyde-Smith CNBC
09:43AM  4 Reasons Why Lilly is Up More Than 30% This Year So Far Zacks
Nov-25-18 09:41AM  The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings Benzinga
09:35AM  9 Policy Catalysts For Health Care Investors To Watch Before Year's End Benzinga
Nov-22-18 07:23AM  Roche, AbbVie Get FDA Approval for Venclexta Label Expansion Zacks
Nov-21-18 04:19PM  This Highly Rated Pharma Giant Is More Than Just A Diabetes Player Investor's Business Daily
04:00PM  Amgen To Present At the Piper Jaffray And Evercore ISI Healthcare Conferences PR Newswire
11:21AM  Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal Zacks
09:47AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
06:00AM  5 Quality Blue Chips to Thrive in Bull and Bear Markets Investopedia
Nov-19-18 05:50PM  Amgen (AMGN) Gains As Market Dips: What You Should Know Zacks
09:45AM  Is Amgen (AMGN) a Great Stock for Value Investors? Zacks
09:43AM  Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension Zacks
09:35AM  Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs Zacks
Nov-17-18 04:27PM  Barron's Picks And Pans: Apple, Amgen, TreeHouse Foods And More Benzinga
Nov-16-18 10:39AM  This Biotech Stock Is a Remedy for Tougher Times
09:00AM  Amgen Receives CHMP Positive Opinion To Expand Use Of BLINCYTO® (Blinatumomab) In Patients With Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia PR Newswire
Nov-14-18 04:06PM  Migraine-Focused Biotech Has A Headache On Quarterly Losses Investor's Business Daily
Nov-13-18 02:32PM  Despite Lofty Price, Illumina May Still Be a Buy
07:00AM  Express Scripts offers new formulary for lower list-price drugs Reuters
Nov-12-18 05:50PM  Amgen (AMGN) Stock Moves -0.83%: What You Should Know Zacks
04:00PM  Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific Sessions 2018 PR Newswire
03:18PM  Amgen Is Showing Independent Strength in a Bullish Sign for the Future
09:44AM  Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer Zacks
09:00AM  Amgen Foundation Pledges $500,000 In Relief To Victims Of Ventura And Los Angeles County Wildfires PR Newswire
06:44AM  Investors are flocking to 'quality' stocks. Here's what that means for the market CNBC
Nov-11-18 06:37AM  Better Buy: Amgen Inc. vs. Pfizer Inc. Motley Fool
Nov-09-18 06:59PM  Cramer Remix: Next week's earnings could make or break how the Fed approaches rate hikes CNBC
01:25PM  Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018 Investor's Business Daily
11:02AM  6 Pharmaceutical Stocks to Buy After the Midterms InvestorPlace
Nov-08-18 11:15PM  The Latest: Calif. shooting survivor was at Vegas massacre Associated Press
05:03PM  Coherus prices biosimilar to Amgen's Neulasta at 33 pct discount Reuters
Nov-07-18 10:32PM  Here's Why bluebird bio Fell 21.4% in October Motley Fool
03:43PM  7 Healthcare Stocks Soaring on Election Results InvestorPlace
01:46PM  Amgen Rises 3%
12:22PM  Drug Stocks Climb as Investors Digest Midterm Election Results
09:40AM  Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes Zacks
09:16AM  3 Cancer Stocks to Watch in December Motley Fool
08:23AM  The Zacks Analyst Blog Highlights: Amgen, Intercontinental Exchange, TOTAL S.A., Royal Dutch Shell and Williams Zacks
Nov-05-18 05:50PM  Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:00PM  Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018 PR Newswire
09:00AM  Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease PR Newswire
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Aimovig for the prevention of migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor for the treatment of multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound. The company's marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; Bayer HealthCare Pharmaceuticals Inc.; The University of Texas MD Anderson Cancer Center, and Provention Bio, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM
HENDERSON REBECCA MDirectorAug 10Option Exercise63.113,000189,33016,197Aug 14 08:29 PM
Harper Sean EEVP, Research & DevelopmentJul 16Sale195.711,525298,45856,082Jul 16 08:20 PM
Harper Sean EEVP, Research & DevelopmentJun 12Sale184.271,525281,01257,510Jun 12 07:07 PM
Harper Sean EEVP, Research & DevelopmentMay 14Sale174.101,525265,50359,035May 15 07:52 PM
Piacquad DavidSVP, Business DevelopmentMay 11Option Exercise54.7115,000820,65051,566May 15 07:55 PM
Harper Sean EEVP, Research & DevelopmentApr 12Sale172.681,525263,33756,788Apr 16 07:03 PM
Harper Sean EEVP, Research & DevelopmentMar 16Sale189.751,525289,36965,682Mar 19 08:52 PM
Harper Sean EEVP, Research & DevelopmentFeb 14Sale174.181,525265,62552,089Feb 15 08:57 PM
Harper Sean EEVP, Research & DevelopmentJan 16Sale185.621,525283,07154,673Jan 17 08:19 PM